Compounds for use as iron(III) MRI contrast agents

US12534487B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12534487-B2
Application numberUS-202217682695-A
CountryUS
Kind codeB2
Filing dateFeb 28, 2022
Priority dateMay 19, 2017
Publication dateJan 27, 2026
Grant dateJan 27, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compounds may exhibit a negative redox potential (e.g., relative to a normal hydrogen electrode at a biologically relevant pH, for example, a pH of 6.5-7.5). The compounds can be used as MRI contrast agents.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A macrocyclic core having the following structure: and Z 1 , Z 2 , and Z 3 are each independently H or one or more of the following pendant groups: or a deprotonated analog thereof or a stereoisomer thereof, wherein R is methyl, and Ri is independently a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted alkyl group, and R 1 is not pendant donors; Q 4 and Q 5 are each independently H, OCH 3 , CO 2 H, or substituted or unsubstituted alkyl groups of linear or branched structures, A is a substituted or unsubstituted alkyl group of linear or branched structure with C 1 to C 12 or is a substituted or unsubstituted aryl group or an amino acid, or a salt, a partial salt, a hydrate, a polymorph, or a stereoisomer thereof, wherein the macrocyclic core has structure II or III, Z 1 and Z 2 are each independently a pendant group; wherein for all structures I, II, and III, each of Z 1 , Z 2 , and Z 3 , as applicable, are selected independently of each other, and at least one of R, Z 1 , Z 2 , and Z 3 is different than the remaining R, Z 1 , Z 2 , and Z 3 . 2 . The macrocyclic core of claim 1 , wherein the macrocyclic core has the following structure: and at least one anionic pendant group. 3 . The macrocyclic core of claim 1 , wherein the macrocyclic core has the following structure: 4 . A macrocyclic core having the following structure:

Assignees

Inventors

Classifications

  • the protein being an albumin, e.g. HSA, BSA, ovalbumin · CPC title

  • comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone · CPC title

  • dendrimers, dendrons, hyperbranched compounds · CPC title

  • A61K49/106Primary

    the complex-forming compound being cyclic, e.g. DOTA · CPC title

  • conjugated systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12534487B2 cover?
Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compounds may exhibit a negative redox potential (e.g., relative to a normal hydrogen electrode at a biologically relevant pH, for example, a pH of 6…
Who is the assignee on this patent?
Univ New York State Res Found
What technology area does this patent fall under?
Primary CPC classification A61K49/106. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).